TSCAN THERAPEUTICS INC
Institutional coverage
54 13F filers hold $TCRX.
13F holders
54
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
1 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 54 · Source: 13F-HR01
Zimmermann Investment Management & Planning LLC
1.46% of portfolio
16,038,296 sh
02
Fir Tree Capital Management LP
0.19% of portfolio
11,128,580 sh
03
Wynnefield Capital Inc.
0.02% of portfolio
2,784,792 sh
04
Marshall & Sullivan Inc.
—
1,616,712 sh
05
Evergreen Capital Management LLC
—
1,460,285 sh
06
Eads & Heald Wealth Management
—
1,364,783 sh
07
NJ State Employees Deferred Compensation Plan
0.20% of portfolio
1,245,504 sh
08
Atlantic Edge Private Wealth Management, LLC
—
1,226,255 sh
09
Leuthold Group, LLC
—
1,209,009 sh
10
CFO4Life Group, LLC
—
918,020 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $TCRX in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $TCRX in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:37 UTC.